Plasma N-Glycome Signature of Down Syndrome.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Proteome Research

• Publication date

  2015-09-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jproteome.5b00356PMID 26334954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age-Related Changes of Adaptive and Neuropsychological Features in Persons with Down Syndrome

  2014cited by this paper
• Are glycans the Holy Grail for biomarkers of aging?

  2014cited by this paper
• Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

  2014cited by this paper
• High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification.

  2014cited by this paper
• Total plasma N-glycome changes during pregnancy.

  2014cited by this paper
• Atypical aging in Down syndrome.

  2013cited by this paper
• Glycans Are a Novel Biomarker of Chronological and Biological Ages

  2013cited by this paper
• High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.

  2013cited by this paper
• General mechanism for modulating immunoglobulin effector function

  2013cited by this paper
• N-glycomic biomarkers of biological aging and longevity: a link with inflammaging.

  2013cited by this paper
• Down syndrome as a model of DNA polymerase beta haploinsufficiency and accelerated aging.

  2012cited by this paper
• Changes in plasma and IgG N-glycome during childhood and adolescence.

  2012cited by this paper
• N-glycans in liver-secreted and immunoglogulin-derived protein fractions.

  2012cited by this paper
• Glycans as cancer biomarkers.

  2012cited by this paper
• Altered serum pro-inflammatory cytokines in children with Down's syndrome.

  2012cited by this paper
• Human serum N-glycan profiles are age and sex dependent.

  2011cited by this paper
• Functional analysis of agalactosyl IgG in inflammatory bowel disease patients

  2011cited by this paper
• Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults.

  2011cited by this paper
• High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations

  2011cited by this paper
• Inflammatory and Immunological parameters in adults with Down syndrome

  2011cited by this paper
• Changes in yearly birth prevalence rates of children with Down syndrome in the period 1986-2007 in The Netherlands.

  2011cited by this paper
• Serum N-glycan profile shift during human ageing.

  2010cited by this paper
• Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans.

  2010cited by this paper
• Altered Serum Glycomics in Alzheimer Disease: A Potential Blood Biomarker?

  2010cited by this paper
• The N-glycome of human plasma.

  2010cited by this paper
• Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human Longevity

  2010cited by this paper
• Common aberrations from the normal human plasma N-glycan profile.

  2010cited by this paper
• Health conditions associated with aging and end of life of adults with Down syndrome.

  2010cited by this paper
• International trends of Down syndrome 1993-2004: Births in relation to maternal age and terminations of pregnancies.

  2010cited by this paper
• Modifications of human total serum N‐glycome during liver fibrosis–cirrhosis, is it all about immunoglobulins?

  2010cited by this paper
• Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006.

  2010cited by this paper
• N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing.

  2009cited by this paper
• Variability, heritability and environmental determinants of human plasma N-glycome.

  2009cited by this paper
• Stability of N-glycan profiles in human plasma.

  2009cited by this paper
• Evaluation of the serum N‐linked glycome for the diagnosis of cancer and chronic inflammation

  2008cited by this paper
• N-Glycan profiling in the study of human aging

  2008cited by this paper
• HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software.

  2008cited by this paper
• Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins.

  2008cited by this paper
• Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans.

  2007cited by this paper
• N-Glycomic Changes in Serum Proteins During Human Aging

  2007cited by this paper
• N‐glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus

  2007cited by this paper
• Plasma nerve growth factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down syndrome: an interesting pathway.

  2006cited by this paper
• Glycosylation in cellular mechanisms of health and disease.

  2006cited by this paper
• Risk of death for children with down syndrome and sepsis.

  2005cited by this paper
• Intrinsic abnormalities of lymphocyte counts in children with down syndrome.

  2005cited by this paper
• Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers.

  2005cited by this paper
• Glycans in cancer and inflammation — potential for therapeutics and diagnostics

  2005cited by this paper
• Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics

  2004cited by this paper
• Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds.

  2002cited by this paper
• Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles.

  2001cited by this paper
• Down's syndrome is associated with increased 8,12‐iso‐iPF2α‐VI levels: Evidence for enhanced lipid peroxidation in vivo

  2000cited by this paper
• Medical aspects of school‐aged children with Down syndrome

  1999cited by this paper
• Health care concerns and guidelines for adults with Down syndrome.

  1999cited by this paper
• Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells.

  1999cited by this paper
• Folate and homocysteine metabolism and gene polymorphisms in the etiology of Down syndrome.

  1999cited by this paper
• Biomarkers of oxidative stress are significantly elevated in Down syndrome.

  1998cited by this paper
• Trisomy 21 and accelerated aging: DNA-repair parameters in peripheral lymphocytes of Down's syndrome patients.

  1998cited by this paper
• Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum

  1997cited by this paper
• Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein

  1995cited by this paper
• Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography.

  1995cited by this paper
• Genomic instability and aging. Studies in centenarians (successful aging) and in patients with Down's syndrome (accelerated aging).

  1992cited by this paper
• Genomic Instability and Aging

  1992cited by this paper
• Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity.

  1988cited by this paper
• Genetic syndromes in man with potential relevance to the pathobiology of aging.

  1978cited by this paper

• Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndrome.

  2025cites this paper
• Intricacies of Aging and Down Syndrome.

  2024cites this paper
• Total cell N-glycosylation is altered during differentiation of induced pluripotent stem cells to neural stem cells and is disturbed by trisomy 21

  2024cites this paper
• Joint modeling of an outcome variable and integrated omics datasets using GLM-PO2PLS

  2024influential citation
• The Human Blood N-Glycome: Unraveling Disease Glycosylation Patterns

  2024cites this paper
• IgG1 glycosylation highlights premature aging in Down syndrome

  2024cites this paper
• Epigenomic signature of accelerated ageing in progeroid Cockayne syndrome

  2023influential citation
• Age-Related Changes in Serum N-Glycome in Men and Women—Clusters Associated with Comorbidity

  2023cites this paper
• Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome

  2023cites this paper
• Bio-Metal Dyshomeostasis-Associated Acceleration of Aging and Cognitive Decline in Down Syndrome.

  2023cites this paper
• Total cell N-glycosylation is altered during neuronal differentiation of iPSC to NSC and is disturbed by trisomy 21

  2023cites this paper
• Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity

  2022cites this paper
• Joint Modeling of An Outcome Variable and Integrated Omic Datasets Using GLM-PO2PLS

  2022influential citation
• Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome

  2022cites this paper
• Fractionation and Characterization of Sialyl Linkage Isomers of Serum N-Glycans by CE-MS.

  2022cites this paper
• Blood circulating miR-28-5p and let-7d-5p associate with premature ageing in Down Syndrome.

  2022cites this paper
• Proteomic and metabolomic biomarkers of Alzheimer's disease: Opportunities to advance precision medicine and clinical trials

  2022cites this paper
• DNA Methylation Analysis of Ribosomal DNA in Adults With Down Syndrome

  2022cites this paper
• Epigenomic signature of the progeroid Cockayne syndrome exposes distinct and common features with physiological ageing

  2021cites this paper
• Validation of diagnostic and predictive biomarkers for hereditary angioedema via plasma N‐glycomics

  2021influential citation
• Accelerated biological aging in people with Down syndrome with full and segmental trisomy 21 begins in childhood as revealed by immunoglobulin G glycosylation

  2021cites this paper
• Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

  2021cites this paper
• Permutational immune analysis reveals architectural similarities between inflammaging, Down syndrome and autoimmunity

  2021cites this paper
• Glycosylation and Aging.

  2021cites this paper
• ANALYSIS OF CARBOHYDRATES AND GLYCOCONJUGATES BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY: AN UPDATE FOR 2015-2016.

  2021cites this paper
• Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome

  2020cites this paper
• Glycomics studies using sialic acid derivatization and mass spectrometry

  2020cites this paper
• Targeting Mitochondrial Network Architecture in Down Syndrome and Aging

  2020cites this paper
• Down syndrome, accelerated aging and immunosenescence

  2020cites this paper
• The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation

  2020cites this paper
• Oral microbiome in down syndrome and its implications on oral health

  2020cites this paper
• Adult Vaccinations

  2019cites this paper
• Genetics and genomics of Down syndrome

  2019cites this paper
• Blood‐based biomarkers for Down syndrome and Alzheimer's disease: A systematic review

  2019cites this paper
• Protein Glycosylation: An Important Tool for Diagnosis or Early Detection of Diseases

  2019cites this paper
• A pilot study on machine learning approach to delineate metabolic signatures in intellectual disability

  2019cites this paper
• The smell of longevity: a combination of Volatile Organic Compounds (VOCs) can discriminate centenarians and their offspring from age-matched subjects and young controls

  2019cites this paper
• Impact of Nutrition on Adult Vaccination Efficacy

  2019cites this paper
• Down Syndrome, Ageing and Epigenetics.

  2019cites this paper
• Accelerated bio‐cognitive aging in Down syndrome: State of the art and possible deceleration strategies

  2019cites this paper
• A schizophrenia risk locus alters brain metal transport and plasma glycosylation

  2019cites this paper
• N‐glycome signatures in human plasma: associations with physiology and major diseases

  2019cites this paper
• The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates

  2018cites this paper
• Effluent and serum protein N-glycosylation is associated with inflammation and peritoneal membrane transport characteristics in peritoneal dialysis patients

  2018cites this paper
• Genetics of Human Longevity Within an Eco-Evolutionary Nature-Nurture Framework

  2018cites this paper
• Inflammaging: a new immune–metabolic viewpoint for age-related diseases

  2018cites this paper
• Human aging and longevity are characterized by high levels of mitokines.

  2018cites this paper
• Protein N-Glycosylation in Cardiovascular Diseases and Related Risk Factors

  2018cites this paper
• Glycobiology of Aging.

  2018cites this paper
• Mass Spectrometry Approaches to Glycomic and Glycoproteomic Analyses.

  2018cites this paper
• Plasticity of lifelong calorie‐restricted C57BL/6J mice in adapting to a medium‐fat diet intervention at old age

  2017cites this paper
• DNA Hydroxymethylation Levels Are Altered in Blood Cells From Down Syndrome Persons Enrolled in the MARK-AGE Project

  2017cites this paper
• Inflammaging and human longevity in the omics era.

  2017cites this paper
• Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study.

  2017cites this paper
• Towards personalized diagnostics via longitudinal study of the human plasma N-glycome.

  2016cites this paper
• Diet-induced phenotypic plasticity during aging

  2016cites this paper
• Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health*

  2016cites this paper
• Glycomics and glycoproteomics focused on aging and age-related diseases--Glycans as a potential biomarker for physiological alterations.

  2016cites this paper
• Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring

  2015cites this paper